Published in Managed Care Business Week, July 19th, 2005
"Mycobacterium tuberculosis can not only neutralize immune effector functions, but also has the ability to modulate host-signaling cascades involved in the development of these responses. The 19-kDa antigen (Rv3763), a lipoprotein of M. tuberculosis, elicits high levels of interleukin (IL)-12 from macrophages in addition to its powerful immunomodulatory properties, leading to suppression of antigen-presentation signaling cascades.
"The present study was aimed at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Business Week